SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis

TUESDAY, Nov. 12, 2024 -- For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduction in recurrence, according to a study published online Oct. 30 in The BMJ.
Natalie McCormick, Ph.D...